LI Jian, SHU Lixin, LIU Xijun. Establishment and empirical study of drug price index based on Hedonic model[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(6): 564-568. doi: 10.3969/j.issn.1006-0111.2018.06.020
| Citation:
|
LI Jian, SHU Lixin, LIU Xijun. Establishment and empirical study of drug price index based on Hedonic model[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(6): 564-568. doi: 10.3969/j.issn.1006-0111.2018.06.020
|
Establishment and empirical study of drug price index based on Hedonic model
- 1.
School of Pharmacy, Second Military Medical University, Shanghai 200433, China
- 2.
No. 522 Hospital of PLA, Luoyang 471003, China
- Received Date: 2018-09-06
- Rev Recd Date:
2018-11-12
-
Abstract
Objective To establish the drug price index based on Hedonic model and conduct empirical analysis. Methods From the monitoring data management center for clinical application of antimicrobial agents of CPLA, the official website of the former China drug administration (CFDA) and the website of pharmaceutical intelligence, data related to antimicrobial drug consumption from October 2014 to June 2017 were collected and the empirical analysis was conducted by the Hedonic price index. Results The price index based on Hedonic model showed a downward trend. The effective component content, daily dose number (DDDs), average daily cost of drugs (DDDc), maximum price of drugs and minimum price of drugs were positively correlated with the price index, while the price index was negatively correlated with oral drugs, number of manufacturers of the same variety, medical insurance drugs, number of domestic drugs and number of drug users. Conclusion The drug price index established based on Hedonic model covers 10 characteristic attributes, which could effectively reflect the impact of supply and demand changes on drug prices.
-
References
|
[1]
|
马芳芳, 吴晶. 药品价格指数的方法学综述[J]. 中国卫生政策研究, 2015, 8(7):61-67. |
|
[2]
|
董朝晖, 刘国恩, 吴晶,等. 药品价格政策对抗生素价格的影响:来自北京地区的实证分析[J]. 中国药物经济学, 2008(5):9-14. |
|
[3]
|
吴晶, 刘国恩. 中国药品价格和数量指数及偏倚的实证分析[J]. 中国药物经济学, 2011(1):7-17. |
|
[4]
|
DE HAAN J,VAN DER GRIENT HA. Eliminating chain drift in price indexes based on scanner data[J]. J Econ, 2011, 161(1):36-46. |
|
[5]
|
COCKBURN IM, ANIS AH. Hedonic analysis of arthritis drugs[M]//.Medical Care Output and Productivity, Cambridge, MA:MIT Press, 2001:439-462. |
|
[6]
|
SUSLOW VY. Are there better ways to spell relief:A Hedonic pricing analysis of ulcer drugs[M]. School of Business Administration, University of Michigan, Working Paper, 1992:696. |
|
[7]
|
LUCARELLI C,NICHOLSON S. A quality-adjusted price index for colorectal cancer drugs[M]. National Bureau of Economic Research, Working Paper, 2009:15174. |
|
[8]
|
雷怀英, 朱钰, 高艳云. 基于质量调整的Hedonic价格指数研究[J]. 统计研究, 2007, 24(10):54-56. |
|
[9]
|
马芳芳, 吴晶.天津市抗微生物类基本药物与医保非基本药物价格水平比较[J]. 中国药学杂志, 2015, 50(3):269-273. |
|
[10]
|
倪钎,韩晟,乔杰,王海燕,江滨,胡茵,史录文.[J].中国药事,2007,21(10):801-804. |
|
[11]
|
盛骤, 概率论与数理统计(第三版)[M]. 北京:高等教育出版社,2001. |
-
-
Proportional views
-
DownLoad: